Fedora Pharmaceuticals Receives Support from the Government of Canada to Battle Antimicrobial Resistance with Novel Pipeline of Antibiotic Candidates
16 janv. 2017 10h51 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta , Jan. 16, 2017 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. announced they have received non-refundable financial contribution from the National Research Council of Canada’s...
Fedora Pharmaceuticals Receives Alberta Life Sciences "Company of the Year" Award
30 nov. 2015 10h00 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 30, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that it was named "Company of the Year" by BioAlberta during the Association's 16th Annual General...
Fedora Pharmaceuticals Inc. Receives 2015 ASTech Award for Outstanding Commercial Achievement
09 nov. 2015 16h43 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Nov. 9, 2015 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals Inc., a biotechnology company headquartered in Edmonton, Alberta, Canada, announced their receipt of the 2015 Outstanding...
Fedora Pharmaceuticals Demonstrates that FPI-1465 Increases Activity of Certain Antibiotics against Drug-Resistant Bacteria
12 sept. 2013 13h00 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 12, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. and its collaborators presented
results of preclinical studies demonstrating that FPI-1465 increases
the activity of...
Fedora Pharmaceuticals Unveils Details of Antibiotic Resistance Program in 10 Posters at 2013 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
27 août 2013 08h00 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Aug. 27, 2013 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced that the Company
and its collaborators will be presenting 10 posters at the upcoming
Interscience...
Fedora Pharmaceuticals Appoints Ronald Odynski and Dr. Leonard Post to Newly Created Board of Directors
31 oct. 2012 08h00 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Oct. 31, 2012 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced the creation of a
Board of
Directors and appointment of Leonard E. Post, Ph.D. and Ronald
W. Odynski,...
Fedora Pharmaceuticals Appoints Thomas R. Parr, Ph.D., Chief Scientific Officer
05 sept. 2012 10h00 HE
|
Fedora Pharmaceuticals, Inc.
EDMONTON, Alberta, Sept. 5, 2012 (GLOBE NEWSWIRE) -- Fedora Pharmaceuticals, Inc. today announced the appointment of
Thomas Parr,
Ph.D. to the newly created role of chief scientific officer.
Dr. Parr...